PDF file       product list       search       home page       email       legal notice    

ABX  advanced biochemical compounds   

Product Order number / Unit

9760 TETA-Octreotide acetate 9760.0001: 1 mg per vial
9760.0010: 10 mg per vial
Please inquire for customized filling and bulk quantities.

Precursor for radiolabelled TETA-Octreotide
Ligand for somatostatin receptors
Molar Mass: 1433.70
[226084-96-4] (net peptide)
Colourless to off-white freeze-dried solid packaged in screw cap vials.
Purity: ≥ 97 %
CoA; MS (identity); HPLC (purity)
Chemical Name:
Sequence: TETA-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr(ol), cyclic disulfide
TETA = (4,8,11-Triscarboxymethyl-1,4,8,11-tetraaza-cyclotetradec-1-yl)-acetyl
Supplied as acetate salt
TETA-Octreotide; TETA-OC; CA index name: L-Cysteinamide, N-[[4,8,11-tris(carboxymethyl)-1,4,8,11-tetraazacyclotetradec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-phenylalanyl- D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide
Anderson C.J. et al. 64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors. J Nucl Med. 2001, 42, 213-21.
Lewis J.S. et al. Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model. Clin Cancer Res. 1999, 5, 3608-16.
Anderson C.J. et al. Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor-bearing rats. J Nucl Med. 1998, 39, 1944-51.
date of product catalogue issue: 10 May 2017


  PDF file       product list       home page       search       email       legal notice